RINALI PATEL: Open Payments
NPI 1588293575 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,233 in 53 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $978 · 2025 $1,233
Food & beverage: $1,233
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $258 |
| ViiV Healthcare Company | 8 | $227 |
| Novo Nordisk Inc | 10 | $226 |
| PFIZER INC. | 6 | $138 |
| Gilead Sciences, Inc. | 4 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Lilly USA, LLC | 3 | $70 |
| Exact Sciences Corporation | 2 | $61 |
| Dexcom, Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $27 |
Products named: APRETUDE, UBRELVY, Wegovy, Ozempic, TRINTELLIX, NURTEC ODT, QULIPTA, VRAYLAR.
Industry payments across DC — which companies pay providers there.
